AUG 7·SEC EDGARLow
KUEBLER CHRISTOPHER A sold $1.4M of WAT
KUEBLER CHRISTOPHER A sold 3,626 shares of WATERS CORP /DE/ (WAT) at $397.94 ($1.44M total) on 2026-08-06.
StockNYSE · US · USDHealthcare · Diagnostics & Research
$WAT
WATERS CORP /DE/
Price · $WATvia TradingView
AI sentiment · 7d10 articles
- Bullish
- 8
- Neutral
- 2
- Bearish
- 0
Top stories · $WATMore →
AUG 6·simplywall.st
Waters (WAT) Is Up 5.1% After Raising 2026 Revenue Guidance Amid Integration Progress – What’s Changed
Waters (WAT) reported Q2 sales of $1.65B versus $771M a year earlier, with net income turning to a $136M net loss. The company raised 2026 revenue guidance to $1.75–1.76B for Q3 and $6.42–6.48B for full year, citing 9% organic constant-currency growth and progress integrating acquired BD businesses, plus a new Xevo TQ Absolute XR IVD system.
AUG 6·yahoo.com
Waters Corporation Q2 2026 Earnings Call Summary
Waters Corp reported 9% organic constant-currency growth in Q2 2026, citing strength in pharma and academic end markets and a 400 bps growth acceleration in newly acquired Biosciences and Diagnostic Solutions. The company raised 2026 organic revenue guidance to 7-9%, expects acquired businesses to exit 2026 at 6%+ growth, and projects mid-teens adjusted EPS growth with margin expansion.
WAT sentiment & insider activity
Over the past 7 days, alphai's AI scored 10 news stories mentioning WAT (WATERS CORP /DE/). Coverage has skewed bullish: 8 bullish, 2 neutral, and 0 bearish.
Recent WAT coverage spans earnings, insider activity and market movers.
In the last 30 days, WAT insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($1.4M). The most active reporter was KUEBLER CHRISTOPHER A with 1 filing.
What's driving WAT
The filing discloses an insider sale, which can be read as mild negative sentiment but is not, by itself, a fundamental catalyst.
Raised guidance and product/integration updates are near-term positives, but GAAP losses and integration execution risk keep the risk-reward mixed.
Guidance raise plus quantified integration and restructuring targets should support near-term sentiment, while FX and China DRG headwinds remain key offsets.
Near-term sentiment is being driven by revenue growth from the acquired businesses, while GAAP EPS remains a loss due to acquisition costs and purchase accounting.
The earnings beat plus upward guidance is a direct catalyst for near-term repricing and momentum in WAT.
alphai scores every news story that mentions WAT with an AI model for sentiment and relevance, and aggregates insider trades from WATERS CORP /DE/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $WAT
Score
KUEBLER CHRISTOPHER A sold $1.4M of WAT
KUEBLER CHRISTOPHER A sold 3,626 shares of WATERS CORP /DE/ (WAT) at $397.94 ($1.44M total) on 2026-08-06.
2 min readWaters (WAT) Is Up 5.1% After Raising 2026 Revenue Guidance Amid Integration Progress – What’s Changed
Waters (WAT) reported Q2 sales of $1.65B versus $771M a year earlier, with net income turning to a $136M net loss. The company raised 2026 revenue guidance to $1.75–1.76B for Q3 and $6.42–6.48B for full year, citing 9% organic constant-currency growth and progress integrating acquired BD businesses, plus a new Xevo TQ Absolute XR IVD system.
6 min readWaters Corporation Q2 2026 Earnings Call Summary
Waters Corp reported 9% organic constant-currency growth in Q2 2026, citing strength in pharma and academic end markets and a 400 bps growth acceleration in newly acquired Biosciences and Diagnostic Solutions. The company raised 2026 organic revenue guidance to 7-9%, expects acquired businesses to exit 2026 at 6%+ growth, and projects mid-teens adjusted EPS growth with margin expansion.
7 min readWaters (WAT) Stock Rises On Revenue Surge While Losses Cloud Earnings
Waters (NYSE:WAT) shares rose about 6% after Q2 revenue jumped to $1.645 billion, including $817 million from the BD Biosciences and Diagnostic Solutions acquisition. GAAP results showed a net loss of $136 million and basic EPS loss of $1.38, while free cash flow was $202 million. Organic revenue grew 7% reported and 9% constant currency.
4 min readWhy Waters Corporation (WAT) Stock Is Trading Up Today
Waters Corp (NYSE:WAT) shares rose about 5% after the company reported Q2 results that beat Wall Street and lifted full-year guidance. Waters posted adjusted EPS of $3.05 on revenue of $1.65B, with 7% organic growth. The company now expects 2026 adjusted earnings around $14.55 per share at the midpoint.
4 min read
Waters Corp (WAT) (Q2 2026) Earnings Call Highlights: Strong Organic Growth and Raised
Waters Corp (WAT) reported Q2 2026 earnings call highlights, citing strong organic growth and raised guidance. Management said FX translation is expected to reduce full-year revenue by about 60 bps and EPS by $0.25. China headwinds persist in acquired businesses, while guidance implies ~4% constant-currency growth in Q4. Adjusted EBIT margin guidance stays at 28.2%.
7 min read
Waters Corporation (NYSE:WAT) Exceeds Q2 CY2026 Expectations
Waters Corporation (NYSE:WAT) reported Q2 CY2026 revenue of $1.65 billion, up 113% year on year and 1.3% above estimates, with non-GAAP EPS of $3.05, 1.4% above consensus. It guided next-quarter revenue around $1.75 billion and expects 119% YoY growth. Adjusted operating margin fell to -3.7%.
6 min readWaters Posts Loss In Q2; Raises 2026 Guidance
Waters Corporation (NYSE: WAT) reported a Q2 net loss of $136 million, versus net income of $147 million a year earlier. The company said Q2 GAAP results included non-GAAP EPS of $3.05 and revenue of $1.645 billion, above its guidance range. Waters also raised its 2026 guidance, according to its filings.
4 min readWaters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
Waters Corp (NYSE: WAT) reported Q2 2026 revenue of $1.645B, above guidance, with $828M organic revenue (+7% reported, +9% constant currency) and $817M from acquired Biosciences and Diagnostic Solutions. Adjusted EPS was $3.05 (high end of guidance); GAAP EPS was -$1.39. Waters raised full-year 2026 guidance: organic constant-currency growth 7% to 9% and adjusted EPS $14.45 to $14.65.
6 min readWATERS CORP /DE/ (WAT): Results of Operations and Financial Condition
WATERS CORP /DE/ (WAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d163377dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results Second Quarter 2026 Highlights • Total reported revenue o
4 min read